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The low-affinity receptor for IgE, FCERII (CD23), 
plays an important role in IgE-mediated disorders 
such as allergy, atopy, and parasitic infections. In 
humans, the FCERIIb isoform on epidermal Langer-
hans cells is thought to be an important accessory 
tnolecule in the allergen-specific T cell activation in 
atopic dermatitis. Since considerable knowledge 
about the accessory function of Langerhans cells for 
T -cell activation stems from mouse models, and since 
an IgE-bearing Langerhans cell mouse model would 
be useful in studying the pathophysiology of atopic 
dennatitis, we determined whether FCERII was also 
present on murine Langerhans cells. FCERIla, which 
is the major FCERII isoform in Jnice, was found to be 
constitutively expressed on spleen cells fronl nornlal 
tnice but was not present on epidermal Langerhans 
I n contrast to mos t Fc receptors be longing to the immuno-globulin superfa mily, the murin e low- affinity reccptor for IgE, FCE.RJI (CD23), is a type [] lectin-like g lycoprote in [1-2]. Two sub types of FcElUl occur in humans: FcElUla (homologous to the murinc CD23) is constitutively ex-
pressed on B cells, and FcElUlb (differing only b y a few amino acids 
in the in trace llul ar domain) is found o n eosinophils, m onocytesl 
macroph agcs, B cells, T cclls, and dendritic cells [3] including 
Langerhans cells [4] and epidermal kcratinocytes [5]. Even thoug h 
thcse human FcElU I sub types share an iden tical extracellular 
domain [6-7], they ha ve been functiona ll y diffe re ntiated in tba t 
FCERJla-express ion of cell s is associated w ith FCER.II-mediated 
endocytosis [8] whereas FCERIIb is assoc iated with IgE-m ediated 
phagocytosis [8-9]. Patients with h yper-l gE syndromc or atopic 
dermatitis ha ve increascd numbers of FCERlI + monon uclea r cell s in 
their peripheral blood [10-11]. Incrcased numbe rs of FCEIUI + 
Langerhan s cell s are present in the epidermis [1 2] and dermis [1 3] 
of atopic patients. Sin ce FCEIUl on antigcn presentin g cells (B cclls) 
can foclls IgE-complexed antigen for presentation to hum,Hl T cell s 
w ith incrcased efficacy [1 4 -1 5]. FcelUI-mcdiatcd antigen uptakc 
may play an impo rtan t ro le in a ll e rgen-specific T-cell activation in 
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cells. When interleukin-4, a known indricer of 
FCERII, was adtninistered ill '';''0, FCERII-specific 
I11RNA and protein was significantly upregulated in 
spleen cells but not in Langerhans cells. D e no"o 
synthesis of FCERII was also induced in ,,;t1'O by inter-
leukin-4 on spleen cells, but not on epiderl11al cells. 
The presence of a recently cloned l11urine counter-
part to the hUl11an FCERIlb isoform on murine Lange-
rhans cells could also be excluded on the protein and 
mRNA level because of the high degree of hOl11ology 
to 1110use FcEi~IIa. Taken together the data indicate 
that l11urine epiderl11al Langerhans cells do not ex-
press the low-affinity receptor for 19B. Key words: 
mOl/se CD23Iitlterlel/kill-4Iillteifeyoll-yltrypsin. ] Itwest 
Derll/atof 106:221-224, 1996 
the slcin [1 6-17]. T he demon stration of;/I ";"0 binding of IgE to 
Langerhans cells and dermal dendritic cells in patients with atopic 
de rmatitis su pports this hypothesis [1 2, 18]. 
The purpose of this study was to determine whether FcElUI is 
expressed o n murine Langerhans cells-as it is in those of humans. 
T he presence of FCERII on murine Langerhans cell s would provide 
a lIseful model to study th e role of Langer han s cells in IgE-mediated 
slcin disorde rs both ;/1 ";"0 and i/l ,,;/ro. We were unable, however , 
to detect FCERII protein or FCEIUI- specifi c mRNA in murine 
epiderm al cells wlder conditions that induced significant expression 
of FCEIUl by murine spleen ceI.1s. 
MATERIAL AND METHODS 
Mice BALB/c and C3 H/ H EN female mice were obtained from the small 
animal facility of the National Cancer Institute (Frederick, MD) and were 
used at 8-12 wk of age. 
Reagents R.ecombinant murine interlcukin-4 (mIL-4) and murine iJlter-
feron-y (mlFN-y) were purchased from Boehringer Mannheim (Raritan. 
NJ) . A neutralizing anti-mouse 1L-4 monoclonal antibody (MoAb) 1 D 11 .2, 
a biotinylaced rat IgG2a MoAb to mOuse CD23 (B3B4) and Texas 
red-labeled mouse IgE were a gift of Dr. Fred Finkelman, Uni(omled 
Services University of the Health Science (Bethesda, MD). Directly fluo-
rescein isothiocyanate (FITC)-Iabeled MoAb to FcelU IICD23 (B3B4) , 
FcyIUI/CD32 (2.4G2), and isotype controls (rat IgG l, rat IgG2a) were 
purchased fro m Pharmingen (San Diego, CAl. A FITC rat IgG2b MoAb 
against mOllse IAd .k antigen (MS) was purchased froll1 ATCC (Rockville, 
MD) . 
Culture Mediun, A complete medium was used consisting of RPMI 
1640 (Gibeo, Grand Island, NJ) supplemented with 10% heat-inactivated 
feta l bovine semin (BioAuids). 100 U/ ml penicillin, "100 J.Lg/ ml streptomy-
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cin, 2 mM L-glutamine, 10 mM Hepes, 0.1 mM nonessential amino acids, 
1 mM sodium pyruvate (all from Gibco), and 5 X 10- 5 M 2-mcrcaptoetha-
nol (Sigma C hemical Co ., St. Louis. MO). 
Preparation altd Culture of Epidermal Cells and Spleen Cells 
Fresh epidermal ce ll s were prepared as described from the trypsinized cars 
of syngeneic mice (19) and were cu.ltured overnight at 37°C in cu lture 
medium alone or in the presence ofm lL-4 (10 U/ml), mlFN-y (100 U/ml) 
or the combination of both cytokines. The next day, epidermal ce ll s were 
enriched for Langerhans ce ll s by gradient centri fugation and were re:.cted 
with various antibodies (10-15 ILg/m l) prior to fluorescence-activated cell 
sorter (FACS) analysis. Single cdl suspensions n:om mOLlse spleens were 
prepared by mechanica l disaggregation using forceps. Splenic erythrocytes 
were subjected to hyperosmotic lysis by incubation with ACK lysis buffer (2 
min at room temperature) and the remaining splenic leukocytes were 
washed three times in Hanks' balanced salt so lution -I- 5% fetal bovine 
se rum and were cultured overnight at 2 X lO('/1111 in cu lture 111CdiLllTI und e r 
conditions identica l to those for epidermal ce ll s. Viable ce ll s were enriched 
by grad ient centrifugation and were then sta ined with a panel of antibodies 
for FACS ana lysis. 
Preparation of Epidermal Sheets Mouse cars were split and carti lage 
and subcutaneous fat was removed. Epidermal sheets were prepared (20) 
from these cars by incuba tion (20 min at 37°C) in a NH.,SCN buffer at pH 
6.B. After removal of the dermis, epidermal sheets were attached to glass 
slides and were fixed in acetone (10 min at - 20°C) prior to staining. Then, 
each preparation of mouse epidermis was incubated with 100 ILl of a 
FITC-labeled MoAb (10-15 ILg/ml) or isotype control for 30 min at room 
temperature. Slides were then washed three times with phosphate-buffered 
sa1.ine (PBS) and were mOllnted immediately. 
Phenotypic Attalysis of Cells by Flow Cytometry Epidermal and 
spleen ce lls were washed twice in PBS supplemented with 5'1., fetal bovine 
serum and 0.02% NaN" the buffer used in all subsequent washes. One 
million cell s were incubated with 15 ILl of FITC-labeled or biotinylated 
specific or control antibody (mouse 19G2a) at 10-1.5 ILg/ ml at 4°C for 30 
min. Binding of the biotinylated MoAb was visualized by a second 
incubation w ith streptavidin-phycoerythrin (Zymed, San Francisco. CAl at 
I :1000 for 30 min at 4°C. After three washes, samples of :I 0" viable cell s 
were ana lyzed by Aow cytometry on a FACScau II (Becton Dickinson) 
using the Consort 30 or FACScan software program. Dead cells were gated 
out by the uptake of propidiulll iodide (50 /.Lg/ml in PBS). 
Injection of IL-4/anti-IL-4 Complexes Mke were injected in trave-
nously with either 1 ml of recombinant m1L-4 (3 ILg) complexed with 
ami-I L-4 antibody '1 Dl 1.2 (15 ILg) or 1 ml of PBS alone according to the 
protocol of Finkelman cI nl (21). After 3 d, animals were sacrificed, and 
si.ngle cell suspensions were prepared from spleens and epidermal sheets as 
described above. 
Reverse Transcription Polymerase Chain Reaction and Liquid 
Hybridization mRNA from 50 X 10" epidermal or sp leen ce ll s was 
extracted using superpararnagnctic polystyrene Dynabcads O ligo(dT),s 
(Dynal, Great Neck, NY) as described previously [22]. The concentration 
of the isolated mRNA was determined by its optical density at 260 nm using 
the Warburg-Christian eq ua tion (Beckman DU-60 Nucleic Acid Soft-Pac). 
Nine nanograms of mRNA for FCERII (CD23). a -chain of I-A antigen 
(I-Aa) , and glycera ldehyde-3-phosphate-dehydrogenase (G3PDH) tran-
scription was reverse transcribed by specific priming to f.rst strand cDNA 
using the GeneAmp RNA PCR kit (Perkin Elmer Cetus. Norwalk, CT). 
Amplifica tion of cD NA was performed by the polymerase chain reaction 
(PCR) with a Perkin Elmer Cetus DNA T hermal Cycler. The cycling 
conditions (23 cycles) were 1 min at 94°C, 1.5 min at 55°C . 2 min at 72°C. 
T he primer sequences for FCEJUI were 5'-AGAAAGCGTTGCTGCTGT-
GCAAGAC (5' primer) and 5'-TCAAGCCCAGGGATTTGATGTTGAC 
(3' primer). These primers were designed accord ing to published FcelUI 
sequences and span five introns [23). T he seguences of the primers for 
G3pDH were 5 '-TCATGACCACAGTCCATGCCATCAC (5 ' primer) 
and 5 ' -GCCGTATTCATTGTCATACCAGGAAATGA (3 ' p.imer) ; the 
primers for I-A a were 5'-TCCTGGAGACATTGGCCAGT (5' primer) and 
5'-TCATCGTCAGAAGGGATGAA (3 ' primer). Primers, ml"(.NA concen-
trations and PCR. cycles Were titrated to estab lish standard curves to 
demonstrate linearity allowing quantitative analysis of signal strength. Five 
micro li ters of amplified PCR. product were hybridized to an excess of 
' 2P-endlabcled probe as desc.ibed [22). The sequences of the probes were 
5'-C AGGTTCTGGGAGAGTTTTGAGTTC (FceJUI), 5'-CCTCATTG-
GTAGCTGGGGTG (I-A a ), and 5'-GAGTGGGAGTTGCTGTTGAAGT-
CGC (G3PDJ-I). All probes were complementary to in temal segllences of 
the specific PCR products. After hybridization, samples were separated on 
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4% polyacrylamide gels. dried , and the signal intensity was determined by 
autoradiography. 
RESULTS 
Constitutive Expression ofFcElUI on Spleen Cells, but Not 
on Epidermal Cells in Normal Mice In preliminary experi-
ments, spleen cell s from BALB/c a nd C3H/HEN mice were stained 
with the biotinylated MoAb B3B4 aga inst mouse FaR] [ showing a 
similar degree of FCERlI express io n (data not sh own) . Subsequent 
experiments were therefore performed o nly in BALB/c mice. [n 
contrast to spleen cells , epidermal cells that were tl'ypsinized (to 
obtain a sing le cell suspension) prior to staining with B3B4 did not 
express FCERlI (data not shown) . FCEIl...U + splee n cells were also 
incubated with a 0.25'Yo trypsin solution for 5-45 min prior to 
sta ining. Iml11unOl:eactivity to M oAb B3B4 wa s already absent on 
sp leen cells after 5 min of treatment with trypsin (data not shown) 
indicating that FCERlI expl'ession was trypsin sensitive. 
Furthermore, we determ ine d whether 19E was bound to cells of 
the epidemlis b y in cu bating epiderm ;.1 sheets with Texas red-
labeled mouse IgE (gift of Dr. Fred Finkelman) for 60 min at 1'00111 
temperature followed by immunofluorescen ce microscopy. No 
specific binding was detected (data not sh own). In contrast, I-A 
antigen (major histocompatibility comp lex class II) expression was 
strongly detectable on Langerhans cell s o n ep idermaJ sheets after 
sta ining with the biotinylated MoAb M5 (data not shown) . 
IL-4 Induces de Novo Synthesis of FceRII on Spleen Cells, 
but Not on Epidermal Cells ill Vitl'O IL-4 is known to be a 
potent inducer of FCERII on resting B ce lls and-like IFN-')'-on 
human Langerhans cells [4,24]. To induce de ilOilO synthesis of 
FCERII, epidermal and spleen cells from normal mice were 
trypsin.ized prior to overnight cu lture with or without lL-4 and/or 
IFN-')'. Epidermal and sp leen cells were stained with r1 gG2a 
(isotype control) or M oAb B3B4 against FCERJI. Expression of 
FCERIl on spleen cells cultured in medium alon e was n ot altered in 
the presence of [FN-')' but was significantly in creased in cultures 
with IL-4 (Fig 1A). Adding IFN-')' to c ultures with IL- 4 had no 
synergistic e ffec t on the induction of FCEIUl expression on spleen 
cells (data not shown) . In contra st, epide rmal cells did not express 
detectable FcdUI protein after overnight c ulture in the absence or 
presence of IL-4, IFN-')' (Fig 1B). or the combination of both 
cytokin es (data not shown). 
III Vivo Induction of FceRII Expression on Spleen Cells by 
Injection ofIL-4/Anti-IL-4 Complexes Intravenous injection 
of LL-4 is known to induce FCERlI on murine B lymphocytes [21.] 
and its biological effect can be prolonged if the lL-4 is complexed 
with anti-IL-4 antibodies [21] . We the refore injected IL-4/anti-
IL-4 complexes (or PBS as a control) intraveno usly into BALB/c 
mice, whjch were sacrificed 3 d later according to the protocol of 
Finkelman e/ al [21]. Epide rmal sheets were prepared from mouse 
ears and sing le cell suspensions from the spleen. Spleen cells from 
mice injected with lL-4/anti-IL-4 showed an inc reased express ion 
of FcdUl compared with spleen cells from PBS- Or IFN-,),-injected 
mice (data not shown). In contrast, epidermal sheets from PBS-
injected 01' IL-4/anti-LL-4-treated mice (reac ted with FITC-Ia-
beled MoAb 133B4) did not display stai nin g for FCERII (data not 
shown) . T h e expression of I-A antigen 011 Langerhans cells, 
however, was increased on e pidermal sheets from IL-4/ant1-IL-4 -
treated mi ce (data not shown) . 
FceRII Message Is Not Detected in Epidermal Cells from 
Mice Injected with IL-4/Anti-IL-4 Complexes Suspension 
of epidermal and spleen cell s were prepared from mice injected 
either with PBS or IL-4/anti-lL-4 . Mice were sacl'ifi ced 4, 1. 0, 24. 
and 72 h after injection. Using reverse transcriptase PCR, no 
message for FCERl l was detectable in epiderma l cells fi'om PBS- or 
IL-4/anti-I L- 4 complex-injected mice (Fig 2). In contrast, mRNA 
for FCEIUI was detected in spleen ce lls fi'om untreated mice at all 
time points (Fig 2) and was increased 4 h after injection of 
IL-4/anti-IL-4 compl exes (Fig 2). M essage for I-A a (a-chain) 
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Figure 1. IL-4 induces de 110110 synthesis of Fc€RII on spleen cells. 
but not on epidernlal cells. ill vit.ro. Single cell suspensions were 
prepared from the epidermis and spleen of untreated BALBI c mice as 
desc ribed in Materia ls al1ll Metlwds. Epidermal cell suspensions were prepared 
by incubation of sheets in 0.25% trypsin for 45 min. alld spleen cell s were 
incubated in 0.25'!!" rrypsin for 45 min after mechanical disaggrega tion . 
Epi dermal and spleen cells were then cu ltured o vernight in culture medium 
with or without either 10 U/ ml IL-4 or 100 U / ml IFN-y. Afterwards, cell 
suspensions were enriched for viable ce ll s by gradient centrifugation prior to 
staining with dgG2a (-.. . ) or MoAb B3B4 against the FCERJI. Trypsinized 
spleen cells cultured in medium alone express low FCER.II (Pallel A, ... ). 
FCEIUl is induced on a sllbpoPll lation of spleen cells in the presence of IL-4 
(Pa /lel A, - - -), but not of lFN-y (P,/IIeI A, ..... ). In contrast. epidermal cells 
do not express FCERJI after overnight culture in medium alone (Pall"! B. 
... ), with IL-4 (PQl/c/ B. - - -) , or with IFN- y (Pallei B ...... ). 
an tigen was detectable in epidermal and spleen cells from PBS-
treated mice and was upregulated in spleen cells 4 h after injection 
of IL-41 anti-lL-4 complexes (Fig 2). 
DISCUSSION 
Several molecules with IgE-binding properties have been demon-
strated o n human Langerhans cells. The high-aflinity receptor for 
IgE. FCERJ, has been shown to be the major IgE-binding mol ecule 
o n epidermal Langerhans cells in normal individuals in that MoAb 
against the FCEIU, but not against FCERll or FcylUI abrogated 
entirely the IgE binding to Langerhans cells on cryostat skin 
sections [25-26]. The presence of FCERll on Langerhans cells has 
been linked to the pathogenesis of TgE-mediated allergic skin 
diseases such as atopic dermatitis: FCER .. n + epidermal Langerhans 
cells were detected in atopic skin [12-13] . Langerhans cells in 
atopic skin have enhanced IgE binding ability [18] . FceIUT + 
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Figure 2. Spleen cells, but not epidermal cells. show significant 
nlRNA message for Fc€RII. which is increased 4 h after injection of 
IL-4/anti-IL-4 complexes. Mice were injected intravenously with eicilcr 
recombinant mouse fL-4 (3 J-Lg) complcxed with anti-IL-4 antibody 1 D11 .2 
('15 J-Lg) or PBS alone. Four ho urs later, animals were sacrifi ced and 
epidermal o r spleen ce ll suspensions were prepared . Samples of mRNA 
were subjected to reverse transcriptase pe R as described in /v/lI (erial" Q/ld 
Methods. Epidermal cell s from PBS- or lL-4/anti-fL-4-treated mice lack a 
signal for FCERIl but do express mRNA for I-Aa (a- chain). In contrast. 
m essage for FCERII is expressed in spleen cells fro m PBS-treated mice aJld 
is upreglllatcd 4 h after injection o f IL-4 /an ti-IL-4 complexes. IAa mRN A 
is expressed in spleen ce ll s from PBS-injected mice and is upregnlated in 
spleen cell s 6:om mice injected w ith IL-4lanti-IL-4 complexes. 
Langerhans and dendritic cells were found to be increased in patch 
test reactions to aeroallergens in atopic dermatitis [13 ,27] , and 
allergen presentation by Langerhans cells from patients with atopic 
dermatitis is m ediated by 19E [16]. In mice, expression ofFcERII on 
B cells has been proposed as an important regulator in the synthesis 
of IgE in all ergic responses [28-29] and parasitic infections 
[1-2 ,30). 
Human FCEIUI occurs in two isoforms, a and b , which display 
distinct modifications in their cytoplasmi c amino-terminal tail [31]. 
T he FCEIUla (homologous to the murine CD23) is found 0 11 human 
B cells and is mainly upregulated by IL-4 [1] . The human FCERlIb 
isoforl11 , which is expressed on monocytes, eosinophil s. platelets. 
dendritic cells [3] , and epidermal LangerhallS cell s. is mainly 
induced by IL-4 and IFN-y [4-5] , and lacks a definitive murine 
counterpart. 
In mice, B cells express significant levels of FCER.TI (isoform a) i(l 
lIillo [23-29.3 1,32] . In this study, we were able to induce th e 
expression ofFcERII (CD23) on mouse spleen cells by exposure to 
IL-4 ;(1 lIi()() and ;(1. lIilro. FCERil (mRNA and protein), however, was 
neither constitutively expressed on murin e Langerhans ceUs nor 
could it be upregulated by exposure to lL-4 or TFN-y i" lI i,)o and ill 
,);Iro. Although CD23 is trypsin sensitive, it is rcexpressed ou spleen 
cells after overnight incubation. We were thus un able to detect the 
FCEIUla o n murine epidermal Langerhans cells despite the fact that 
this isoform of FCEIU I is the major IgE-binding surface molecule in 
mice and the ce lls were incubated overnight. Conrad el ,,/ [6] and 
Richards ci ,,/ [9] were unable to detect m essage for a murine 
counterpart to the human FCEltlIb. Kondo ct ,,/ , howe ver, recently 
cloned two murine FCEIUl one of w hich was ho mologolls to the 
hum an FcERilb [7] . Transfection of the cDNA for tllC mUl;ne 
FCE.RIIb into COS cells led to the generation of a functiona l surface 
protein that was recognized by MoAb B3B4 against FCERJla and 
was capable of binding IgE [7] . Our inabili ty to induce immuno-
reactivity for anti-CD23a (MoAb B3B4) in epiderm al Langerhans 
cells by stim ula tion with IL-4 and IFN-y [41 makes it unlikely that 
significant amollnts of FCEIUlb are expressed on murine Langer-
hans cells. In addition , we were unable to detect by PC R mRNA 
message for both FCERli isoforms in murine Langerhans cells. 
1t is possible that Langerhans cells m ay display IgE-binding 
sUI·f.'1 ce molecules other than FceR.11. To date , transcrip ts for the 
murine high-affinity receptor fo r 19E, FCERI. w ere only detected in 
mast cells and basophils 133.34]. Takizawa C( ,, / have identifi ed 
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FcyRII and FcyRIU as low-affini ty receptors fo r IgE on murine 
mast cell s and m acrophages [3 4]. Murin e Lan gerhans cell s may thu s 
be able to bind 19E thro ugh their FcyRII receptors. An analog to 
the human IgE-binding pro tein (eBP) w hich is secreted by kerati-
nocytes and binds to Langerhans cells [35] has been detected in 
murine skin by inlmunohistochemistry but is no t well characterized 
[36]. T he definitive absence of FceRII on murine Langerhans cells 
makes the m ouse model unsuitabl e to de termin e the ro le FceRII+ 
Langerhans cens m ay play in the pathogenesis ofIgE-medi ated skin 
disorders. 
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